1. World Health Organization, UNAIDS, UNICEF. Global HIV/AIDS Response, Epidemic update and health sector progress towards Universal Acces 2011. Available from: http://www.who.int/hiv/pub/progress_report2011/hiv_full_report_2011.pdf . Accessed December 21, 2013.
2. World Health Organization. Preferred Antiretroviral Medicines for Treating and Preventing HIV Infection in Younger Children 2008. Available from: http://www.who.int/hiv/pub/paediatric/antiretroviral/en/index.html . Accessed December 21, 2013.
3. L’homme RFA, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, et al. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets. AIDS. 2008;22:557–565.
4. Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, et al. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets. AIDS. 2012;26:1795–1800.
5. National AIDS Control Organization. National Paediatric ART Dosing Schedules Desk Reference 2010. Available from: http://naco.gov.in/upload/Care%20&%20TreatmentNational_Paediatric_ART_Dosing_Schedules_Desk_Reference_Jan_2010.pdf . Accessed:December 21, 2013.